Active anticancer ingredients in Curaderm BEC5 specifically kill cancer cells and additionally stimulate the immune system against cancers

An article recently published in the prestigious journal Planta Medica 2012 (DOI: hhtp://dx.doi.org/10.1055/s-0031-1298149) entitled “solasodine rhamnosyl glycosides cause apoptosis in cancer cells, Do they also prime the immune system resulting in long-term protection against cancer?” by Cham and Chase describes how the active ingredients in Curaderm ^BEC5 programs cancer cell death by a highly organised process.  It was reported that the active ingredients, in Curaderm ^BEC5 were more effective as anticancer agents than many promising newer drugs and older currently much used anticancer drugs.

The exciting parts of the above article is that the anticancer active ingredients (BEC) in Curaderm ^BEC5 not only cure animals suffering from terminal internal cancers, but these ingredients have additional effects of also stimulating immunity against the cancer and causes long term remission.

In a previously published study it was shown that the active ingredients in Curaderm ^BEC5 slowed tumour growth and provided a survival benefit of malignant mesothelioma by stimulation of the immune system.

The observations are of tremendous interest and may play a role in the treatment of skin cancers with Curaderm ^BEC5.  These effects, together with the killing of cancer cells with BEC by a highly organised process, may translate how and why treatment of skin cancers with Curaderm ^BEC5 impressively and astoundingly results in the non comparable cosmetic outcomes.

NEW STUDY SHOWS THAT TREATMENT OF VERY LARGE SKIN CANCERS WITH EGGPLANT EXTRACTS IN A CREAM FORMULATION CURADERMBEC5 RESULTS IN ALMOST UNTHINKABLE COSMETIC OUTCOMES. THE PUBLISHED ARTICLE IS THE MOST POPULAR PAPER OF OVER TENS OF THOUSANDS OF ARTICLES PUBLISHED BY THE SCIRP PUBLISHERS.

An article published in the International Journal of Clinical Medicine in September, 2011 (ijcm, 2011, 2, 473-477,http://www.scirp.org/journal/PaperDownload.aspxpaperID=7563&returnUrl=http%3a%2f%2fwww.scirp.org%2fJournal%2fHome.aspx%3fIssueID%3d1074 ) entitled Topical Solasodine Rhamnosyl Glycosides Derived from the Eggplant Treats Large Skin Cancers: Two Case Reports by Dr. Bill Cham at the Australasian Medical Research Centre has received tremendous interest with a record high downloads/citations when compared with articles of over 150 scientific journals of the same publishers SCIRP.

SCIRP (Scientific Research Publishing) is an academic publisher of open access journals.  It also publishes academic books and conference proceedings.  SCIRP currently has more than 150 open access journals in the areas of science, technology, and medicine.  So the record downloads of the above article means this article has been of interest to readers when compared to more than tens of thousands of other articles published by SCIRP and indeed the Curaderm ^BEC5 article is the most popular ever published by SCIRP.

The above article describes the effectiveness of Curaderm ^BEC5 on two very large skin cancers.  The anticancer active ingredients were extracted from the eggplant or devil’s apple.  Photographs of skin cancers before, during and after treatment with Curaderm ^BEC5 are almost unbelievable.  The patients did not experience any side effects.  At the completion of treatment with Curaderm ^BEC5, it could not be distinguished where the tumours once were!  No other studies using other methods such as surgery even when followed up with surgical cosmetic reconstruction can achieve such results.

Figure 1 shows an example of a Curaderm ^BEC5 treated skin cancer.  In additon to eliminating this large skin cancer with Curaderm ^BEC5, the treatment also improved the quality of life for these patients.  Curaderm ^BEC5 continues to amaze the medical profession.